Mirati Therapeutics downgraded to Neutral from Buy at Citi
PremiumThe FlyMirati Therapeutics downgraded to Neutral from Buy at Citi
11M ago
Mirati Therapeutics’ Krazati receives positive opinion in NSLC from CHMP
Premium
The Fly
Mirati Therapeutics’ Krazati receives positive opinion in NSLC from CHMP
12M ago
Leerink downgrades Mirati to Market Perform as focus remains on acquisition
Premium
The Fly
Leerink downgrades Mirati to Market Perform as focus remains on acquisition
1y ago
MRTX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-EarningsMRTX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
1y ago
Mirati Therapeutics receives MHRA approval for KRAZATI
Premium
The Fly
Mirati Therapeutics receives MHRA approval for KRAZATI
1y ago
Kura Oncology, Mirati Therapeutics enter clinical collab, supply agreement
Premium
The Fly
Kura Oncology, Mirati Therapeutics enter clinical collab, supply agreement
1y ago
William Blair healthcare/biotech analysts hold analyst/industry conference call
PremiumThe FlyWilliam Blair healthcare/biotech analysts hold analyst/industry conference call
1y ago
Ideaya has positive read from Amgen PRMT5 data, says Oppenheimer
Premium
The Fly
Ideaya has positive read from Amgen PRMT5 data, says Oppenheimer
1y ago
Amgen’s PRMT5 drug shows 5 partial responses from 31 patients, STATnews reports
Premium
The Fly
Amgen’s PRMT5 drug shows 5 partial responses from 31 patients, STATnews reports
1y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100